Erythromycin-digoxin toxicity — GPhC CRA MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: B — Erythromycin has increased digoxin levels leading to digoxin toxicity
Erythromycin inhibits P-glycoprotein and CYP3A4, which increases digoxin bioavailability and reduces its clearance, leading to elevated serum digoxin concentrations. The symptoms described — nausea, visual disturbances (classically yellow-green visual changes), and bradycardia — are classic features of digoxin toxicity. Digoxin levels should be checked urgently and the dose likely needs to be reduced or temporarily withheld. The erythromycin interaction should be managed with an alternative antibiotic if possible.
Reference: https://www.pharmacyregulation.org/registration-assessment#stage-8-order-16